Litigation Details for Merck KGaA v. Hopewell Pharma Ventures, Inc. (D. Del. 2022)
✉ Email this page to a colleague
Merck KGaA v. Hopewell Pharma Ventures, Inc. (D. Del. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-10-17 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Parties | AUROBINDO PHARMA USA INC. | ||
| Patents | 7,713,947; 8,377,903 | ||
| Attorneys | Jeremy A. Tigan | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Merck KGaA v. Hopewell Pharma Ventures, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Merck KGaA v. Hopewell Pharma Ventures, Inc. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-06-13 | 141 | Report and Recommendations | States Patent Nos. 7,713,947 (the “'947 patent”) and 8,377,903 (the “'903 patent” and together…together with the '947 patent, the “asserted patents” or the “patents-in-suit”). 2 Presently before… The '947 patent (which issued in May 2010) and the '903 patent (which issued in February…the Court will cite them by their patent numbers only. These two patents-in-suit share a common specification…portions of the '947 patent are also found in the '903 patent. Plaintiffs previously | External link to document |
| 2022-10-17 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,713,947 B2 ;8,377,903 B2 ;10,849,919… 17 October 2022 1:22-cv-01365 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
